Skip to content

Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography

Development and Validation of Multi-scale Deep Neural Network-Based CT Intelligent Diagnosis System for Coronary Vulnerable Plaques: A Chinese Multicenter Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06025305
Acronym
VALUE
Enrollment
2000
Registered
2023-09-06
Start date
2023-07-01
Completion date
2027-12-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Plaque, Atherosclerotic

Keywords

artificial intelligence; coronary CT angiography; vulnerable plaque

Brief summary

The goal of this observational study is to develop an automatic whole-process AI model to detect, quantify, and characterize plaques using coronary CT angiography in coronary artery disease patients. The main questions it aims to answer are: 1. Whether the AI model enables to detect and quantify coronary plaques compared with intravascular ultrasound or expert readers; 2. Whether the AI model enables to identify vulnerable plaques using intravascular ultrasound or optical coherence tomography as the reference standard. 3. Whether the AI model enables to predict future adverse cardiac events in a large cohort of 10,000 patients with non-obstructive CAD. 4. Whether the AI model enables to influnece downstream clincial decision-making.

Detailed description

Coronary artery disease (CAD) remains the leading cause of death worldwide. Atherosclerotic plaques play a pivotal role in CAD-related patient mortality. Thus, the detection, quantification, and characterization of coronary plaques are clinically significant for early prevention and interventions for CAD. Coronary CT angiography (CCTA) has emerged as a robust noninvasive tool for the evaluation of CAD. In clinical practice, the coronary plaque assessment is performed by a time-consuming manual process dependent on the clinician's experience and subjective visual interpretation. With the development of artificial intelligence, many automatic computer-aided methods have been proposed to post-process the CCTA images. However, previously proposed algorithms of plaque evaluation were not developed based on intravascular ultrasound (IVUS) or optical coherence tomography (OCT), which were regarded as the gold reference for plaque evaluation. Thus, we aimed to develop a deep learning model in a whole-process automatic and intelligent system on CCTA to detect, quantify, and characterize plaques using IVUS or OCT as reference standard. Then we will work on the validation in different clinical scenarios: (1) Validation of the accuracy of the new deep learning model; (2) Prognosis of the model in different populations with CAD; (3) Impact of the model on guiding clincial therapies. The main questions it aims to answer are: 1. Whether the AI model enables to detect and quantify coronary plaques compared with intravascular ultrasound or expert readers; 2. Whether the AI model enables to identify vulnerable plaques using IVUS or OCT as the reference standard. 3. Whether the AI model enables to predict future adverse cardiac events in a large cohort of 10,000 patients with non-obstructive coronary artery disease (China CT-FFR study 2). 4. Whether the AI model enables to influnece downstream clincial decision-making in real-world clincial practice.

Interventions

DIAGNOSTIC_TESTIntravascular imaging test

Coronary artery disease patients first underwent CCTA and then intravascular imaging test within 3 months.

DIAGNOSTIC_TESTCoronary plaque assessment

Plaques on coronary CT angiography (CCTA) were quantified and characterized using the developed AI model.

Sponsors

Jinling Hospital, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Intravascular imaging (including intravascular ultrasound or optical coherence tomography) was performed within 3 months after CCTA; * No change in medications or clinical symptoms during CCTA and intravascular imaging examinations; * Coronary artery diameter stenosis of 30% to 90% on invasive coronary imaging.

Exclusion criteria

* Image quality of CCTA or intravascular US was inadequate to analyze; * Intravascular imaging was performed after percutaneous coronary intervention (PCI) or pre-dilation of the target lesions; * Lesions could not be co-registered between CCTA and intravascular US; * Missing CCTA or intravascular US data

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of AI-assisted coronary CT angiography on identifying vulnerable plaques compared to intravascular imaging1 day

Secondary

MeasureTime frame
Overall coronary plaque detection rate using intravascular ultrasound as reference standard1 day
Total plaque volume1 day
Changes in medical management following the addition of the AI model compared with routine CCTA results alone.90 days

Countries

China

Contacts

STUDY_CHAIRLongjiang Zhang, MD

Jinling Hospital, Medical School of Nanjing University, Nanjing,China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026